Literature DB >> 7514344

IGF-II in the pathogenesis of rhabdomyosarcoma: a prototype of IGFs involvement in human tumorigenesis.

C P Minniti1, L J Helman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7514344     DOI: 10.1007/978-1-4615-2988-0_32

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency.

Authors:  Anna Polesskaya; Sylvain Cuvellier; Irina Naguibneva; Arnaud Duquet; Eric G Moss; Annick Harel-Bellan
Journal:  Genes Dev       Date:  2007-05-01       Impact factor: 11.361

2.  A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study.

Authors:  Alberto S Pappo; Gilles Vassal; John J Crowley; Vanessa Bolejack; Pancras C W Hogendoorn; Rashmi Chugh; Marc Ladanyi; Joseph F Grippo; Georgina Dall; Arthur P Staddon; Sant P Chawla; Robert G Maki; Dejka M Araujo; Birgit Geoerger; Kristen Ganjoo; Neyssa Marina; Jean-Yves Blay; Scott M Schuetze; Warren A Chow; Lee J Helman
Journal:  Cancer       Date:  2014-05-02       Impact factor: 6.860

3.  Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectives.

Authors:  Ana Sofia Martins; David Olmos; Edoardo Missiaglia; Janet Shipley
Journal:  Sarcoma       Date:  2011-03-03

Review 4.  Targeting the IGF-1R: The Tale of the Tortoise and the Hare.

Authors:  Caitrin Crudden; Ada Girnita; Leonard Girnita
Journal:  Front Endocrinol (Lausanne)       Date:  2015-04-27       Impact factor: 5.555

5.  The role of insulin-like growth factor system in soft tissue sarcomas: from physiopathology to targeted therapeutic approaches.

Authors:  W Zumkeller
Journal:  Sarcoma       Date:  1998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.